CCN2 and pulmonary fibrosis: Our results demonstrated YAP/TAZ activation and increased expression of CTGF and TGFB in PQ-treated lungs, thus, combined with the impact of YAP/TAZ on PQ-induced cellular senescence, we hypothesized that targeting YAP/TAZ could alleviate PQ-induced pulmonary fibrosis.